Trade Mark Journal No.2026/021 22 May 2026
WO0000001916462 (5)
Office of origin: United States of America
Date of International Registration:14 April 2026
Date of designation in the UK:
14 April 2026

International priority date claimed: 17 October 2025
(United States of America)
(99449790)
- Class 5
- Pharmaceutical preparations for the treatment of pulmonary diseases and disorders; pharmaceutical preparations for the treatment of lung diseases and disorders; pharmaceutical preparations for the treatment of interstitial lung disease.
aTyr Pharma, Inc.
Representative: Brendan J. Hughes Cooley LLP, 1299 Pennsylvania Avenue, NW, Suite 700,, ATTN: IP Docketing Department, Washington DC 20004-2400, UNITED STATES OF AMERICA